Search research articles
Contact Us
Filters
Showing results (1-10 of 56) with videos related to
Page
of 6
Sort By:
The Indian Medical Gazette
|
October 11, 2017
Recurrent Dislocation of Shoulder
Philip Savage
BMC Cancer
|
November 23, 2016
Chemotherapy curable malignancies and cancer stem cells: a biological review and hypothesis
Philip Savage
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
November 27, 2010
Development and economic trends in cancer therapeutic drugs in the UK from 1955 to 2009
Philip Savage
BMJ Clinical Evidence
|
May 21, 2009
Malignant melanoma (non-metastatic)
Philip Savage
Journal of HIV Therapy
|
June 22, 2007
A new approach to immunotherapy: for AIDS and AIDS-related malignancies
Philip Savage
Annals of Clinical Biochemistry
|
January 5, 2006
Tumour markers in cancers of unknown primary: a clinical perspective
Philip Savage
Nature Reviews. Clinical Oncology
|
February 21, 2017
Approvals in 2016: cost-benefit challenges of new anticancer agents
Philip Savage
Frontiers in Genetics
|
June 26, 2020
Chemotherapy Curability in Leukemia, Lymphoma, Germ Cell Tumors and Gestational Malignancies: A Reflection of the Unique Physiology of Their Cells of Origin
Philip Savage
BMC Cancer
|
January 22, 2015
Clinical observations on chemotherapy curable malignancies: unique genetic events, frozen development and enduring apoptotic potential
Philip Savage
Gynecologic Oncology
|
September 3, 2005
The role of repeat uterine evacuation in trophoblast disease
Philip Savage, Michael J Seckl
Page
of 6
Search research articles
Search
Showing results (1-10 of 56) with videos related to
Sort By:
Page
of 6
The Indian Medical Gazette
|
October 11, 2017
Recurrent Dislocation of Shoulder
Philip Savage
BMC Cancer
|
November 23, 2016
Chemotherapy curable malignancies and cancer stem cells: a biological review and hypothesis
Philip Savage
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
November 27, 2010
Development and economic trends in cancer therapeutic drugs in the UK from 1955 to 2009
Philip Savage
BMJ Clinical Evidence
|
May 21, 2009
Malignant melanoma (non-metastatic)
Philip Savage
Journal of HIV Therapy
|
June 22, 2007
A new approach to immunotherapy: for AIDS and AIDS-related malignancies
Philip Savage
Annals of Clinical Biochemistry
|
January 5, 2006
Tumour markers in cancers of unknown primary: a clinical perspective
Philip Savage
Nature Reviews. Clinical Oncology
|
February 21, 2017
Approvals in 2016: cost-benefit challenges of new anticancer agents
Philip Savage
Frontiers in Genetics
|
June 26, 2020
Chemotherapy Curability in Leukemia, Lymphoma, Germ Cell Tumors and Gestational Malignancies: A Reflection of the Unique Physiology of Their Cells of Origin
Philip Savage
BMC Cancer
|
January 22, 2015
Clinical observations on chemotherapy curable malignancies: unique genetic events, frozen development and enduring apoptotic potential
Philip Savage
Gynecologic Oncology
|
September 3, 2005
The role of repeat uterine evacuation in trophoblast disease
Philip Savage, Michael J Seckl
Page
of 6